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Background: Ventilator-induced lung injury (VILI) is characterized by increased alveolar permeability, pulmonary
edema. The tyrosine kinase, c-Src, is involved in VILI but its role has not been fully elucidated. This study examined
the relationship between c-Src activation and occludin levels in VILI both in vitro and in vivo.
Methods: For the in vivo study, Wistar rats were randomly divided into five groups: control (group C); normal tidal
volume (group M); normal tidal volume + c-Src inhibitor (PP2) (group M + P); high tidal volume (group H); and high
tidal volume + c-Src inhibitor (PP2) (group H + P). Rats in all groups but group C underwent mechanical ventilation
for 4 h. For the in vitro study, MLE-12 cells pretreated with PP2 and siRNA underwent cyclic stretching at 8% or 20%
for 0, 1, 2 and 4 h. The expressions of occludin, c-Src, and p-c-Src were analyzed by western blotting, hematoxylin
and eosin (HE) staining, and immunofluorescence.
Results: For the in vivo study, rats in group H showed decreased occludin expression and activated c-Src compared
with group C. HE staining and lung injury score showed more severe lung injury and alveolar edema in group H
compared with group M and group C. Group H + P had less pulmonary edema induced by the high tidal volume
ventilation. For the in vitro study, occludin expression decreased and c-Src activation increased as indicated by the
phosphorylation of c-Src over time. Consistently, PP2 could restore occludin levels.
Conclusions: Mechanical ventilation can activate c-Src by phosphorylation and increase the degradation of
occludin. c-Src inhibitor can ameliorate barrier function and lung injury by up-regulating occludin.
Keywords: Ventilation-induced lung injury, Tight junctions, Occludin, c-Src inhibitorBackground
Ventilator-induced lung injury (VILI) is a common iatro-
genic clinical phenomenon in intensive care and anesthesia
[1]. VILI can, both in vivo and in vitro, decrease oxygen-
ation capacity, increase alveolar membrane permeability,
and induce secondary pulmonary function damage and
acute respiratory distress syndrome [2,3]. Maintaining nor-
mal permeability and the integrity of the alveolar mem-
brane could prevent pulmonary edema, and may play a key
role in inhibiting or reducing the subsequent development
of lung injury [4].* Correspondence: wyldgf@163.com
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unless otherwise stated.The barrier function of pulmonary epithelial cells plays
an important role in maintaining alveolar membrane
permeability and preventing the destruction of alveolar
epithelial cell junctions, which could lead to acute lung
injury and acute respiratory distress syndrome [5-7]. A
recent study demonstrated that the expression of the
transmembrane protein occludin and the tight junction
protein ZO-1 decreased during cyclic mechanical
stretching in primary rat cells [8]. The underlying mech-
anism for how occludin regulates barrier function is not
fully understood.
The c-Src family is a family of non-receptor protein
tyrosine kinases which regulate cell growth, develop-
ment, survival and apoptosis, and the regulation of cell
or extracellular matrix adhesion functions [9]. The role
of c-Src effect on occludin in VILI is unknown.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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VILI to explore the mechanisms behind occludin expression
and c-Src and to obtain data that could be used to assist in
therapies for the prevention and treatment in VILI.
Methods
Materials
Cell culture medium (DMEM/F12) and fetal bovine
serum (FBS) were from Gibco. Rabbit c-Src polyclonal
antibody (SRC 2) was purchased from Santa Cruz Bio-
technology. Rabbit phosphorylation c-Src (Y416) was
purchased from CST. The effective and selective inhi-
bitor of c-Src PP2 (172889-27-9) was purchased from
Cayman Chemical. Rabbit anti-occludin polyclonal anti-
body and rabbit anti-GAPDH polyclonal antibody were
purchased from Invitrogen. Mouse alveolar epithelial
cells (MLE-12) were purchased from American Type
Culture Collection (Manassas, VA).
Cell culture, transient transfection of siRNA and treatment
with c-Src inhibitor
MLE-12 cells were plated at a density of 2.5 × 105 cells/ml
on culture dishes or BioFlex plates with collagen protein
coated in DMEM/F12 and with 10% FBS at 37°C in 5%
CO2, and incubated for 24–48 h. MLE-12 cell monolayers
were serum-deprived for 2 h prior to experiments. For
some experiments, PP2 was added to the plate of conflu-
ent MLE-12 cells 30 min prior to stretching [10,11].
For transient transfection of Occludin-siRNA, siRNA
was synthesized by GenePharma Co., Ltd. (Shanghai,
China). The gene sequences are 5′-GCUCUCUCGUCU
AGAUAAATT-3′ and 5′-UUUAUCUAGACGAGAGAG
CTT-3′. MLE-12 cells were plated at a density of 2.5 ×
105 cells/ml on BioFlex plates with collagen protein
coated in DMEM/F12 and with 10% FBS at 37°C in 5%
CO2, and incubated for 24 h before being washed twice
with PBS. Then siRNA was diluted with 2 mL DMEM/
F12 to remove FBS. INTERFERin (Polyplus-transfection,
France), a transfection reagent, was added and eddied for
10 s. The INTERFERin and siRNA dilution was then incu-
bated at room temperature for 10 min before being fur-
ther incubated at 37°C and 5% CO2 for 48 h. Transfection
efficiency was measured by western blotting [12,13].
For inhibitor studies, when MLE-12 cell monolayers on
BioFlex plates had grown 85–95%, the cells were serum-
deprived for 2 h prior to experiments and treated with Src
inhibitor PP2 100 nM and DMSO 30 μL/mL for 30 min at
37°C and 5% CO2 for cyclic stretching testing [10].
Cyclic stretching
MLE-12 cells on collagen-coated flexible bottom BioFlex
plates were exposed to cyclic stretching using a FX-5000
T Flexercell Tension Plus system (Flexcell International,
McKeesport, PA) equipped with a 25-mm BioFlex loadingstation. After a 48 h culture, cell monolayers were mounted
onto the Flexercell system. We used a pattern of cyclic
stretching at a frequency 0.5 Hz for 30 cycles/min with a
stretch-to-relaxation relation of 1:1 [10,11]. Cyclic stretch-
ing was conducted at 8% and 20% of the change in the
basement membrane surface area applied in a cyclic man-
ner. These surface area changes correspond to 50% and
80% of total lung capacity, respectively [14,15]. Cyclic
stretching time was 1, 2, and 4 h at 37°C in a humidified
incubator containing 5% CO2. A computer controlled all
processes. Non-stretched cells were used as controls.
Comparisons were made between stretched cells and con-
trol cells cultured on the same plates in the absence of
cyclic strain.
Animals and treatments
Thirty healthy Wistar rats weighing 250–300 g were
provided by the Laboratory Animal Center of Shandong
Traditional Chinese Medicine University. All animal
procedures were reviewed and approved by the Labora-
tory Animal Ethics Committee of Shandong University.
Rats were randomly divided into five groups (n = 6 in
each group): a control group (group C); a normal tidal
volume group (group M); a normal tidal volume + c-Src
inhibitor (PP2) group (group M + P); a high tidal volume
group (group H); and a high tidal volume + c-Src inhibi-
tor (PP2) group (group H + P).
Rats in group C did not have mechanical ventilation.
The other four groups were mechanically ventilated for
4 h using an ALC-V8 animal ventilator. The tidal volume
was 7 mL/kg in group M and group M+ P, and 42 mL/kg
in group H and group H + P. Ventilation parameters were
set as follows: a respiratory rate of 40 times/min, I/E ratio
of 1:2, and a fraction of inspired oxygen of 21% [16]. Rats
in group M+ P and group H + P were pretreated with PP2
1 μg/kg for 1 h before anesthesia.
Animals were anesthetized by intraperitoneal injection of
pentobarbital sodium (60 mg/kg) and ketamine (80 mg/kg).
Anesthesia was maintained by infusion of pentobarbital at
15 mg/kg every 30 min via the tail vein. Muscle relaxation
was maintained with pancuronium (2 mg/kg/h) [17]. Rats’
vital signs were monitored with Mouse Ox pulse oximetry
system (Starr Life Sciences Inc, USA).
After ventilation, rats were killed by exsanguination
of arterial blood. Lung injury score was recorded [18].
Acute lung injury was scored according to the following
four items: alveolar congestion, hemorrhage, infiltration
or aggregation of neutrophils in the airspace or the ves-
sel wall, and thickness of the alveolar wall/hyaline mem-
brane formation [18]. Lungs were removed and the right
lung upper lobe was quickly frozen in liquid nitrogen
which was used for western blotting, and the remnant
right lung tissue were fixed in 4% paraformaldehyde for
48–72 h for HE staining. The left lung was used to
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tify the magnitude of pulmonary edema. After measuring
the wet lung weight, tissues were incubated in a 70°C in-
cubator for 72 h to gain the dry weight.
Immunofluorescence and HE staining
For the in vitro study, after cyclic stretching, the plates
were washed with PBS and cells were fixed in 4% formal-
dehyde (10 min) and incubated in 1% BSA for 1 h. Cells
were then incubated with rabbit anti-occludin polyclonal
antibody (1:80 dilution) overnight at 4°C. The secondary
antibody (red) was goat anti-rabbit IgG (H + L) used at a
1/150 dilution for 1 h. DAPI was used to stain cell nuclei
(blue) for 3 min.
For the in vivo study, lung tissues blocked by embedding
in paraffin were sectioned and stained with HE staining.
Hematoxylin was applied for 5 min and eosin for 2 min.
Western blotting
For the in vivo study, tissue fragments were lysed in
radioimmunoprecipitation assay buffer supplemented
with a cocktail of protease inhibitors. For the in vitro
study, for the preparation of total cell extracts, mono-
layer cultures were washed in cold PBS and lysed in the
appropriate amount of RIPA buffer supplemented with
the protease inhibitor PMSF. The lysate was collected
and protein concentration was determined using a
bicinchoninic acid protein assay kit.
Equal amounts of protein were denatured and sepa-
rated on 10% SDS-PAGE gels and then transferred to
polyvinylidene difluoride membranes (Bio-Rad, Hercules,
CA, USA) for electrophoresis at 100 V for 1 h.
After blocking with skim milk (5%), proteins were
probed overnight at 4°C. Anti-occludin was used at a
1:200 dilution, anti-phosphorylation c-Src at a 1:2000 dilu-
tion and anti-c-Src at a 1:1000 dilution. The appropriate
horseradish peroxidase-conjugated secondary antibody
was added to the filters followed by incubation for 1 h at
room temperature with a 1:5000 dilution.
After sequential washing of membranes in T-PBS to
remove excess secondary antibody, signals were detected
by chemiluminescence using the ECL system. Relative
band densities of the various proteins were measured
from scanned films using Image J Software.
Statistical analysis
Representative experiments from at least three inde-
pendent experiments are shown. Statistical analysis was
performed using the SPSS 19.0 statistics package. All
data are expressed as mean ± SD. Statistical differences
were assessed using Student’s t-tests or Tukey and LSD
(L) of one-way analysis of variance (ANOVA), where ap-
propriate among groups. A P-value <0.05 was considered
statistically significant.Results
8% or 20% cyclic stretching mediated the down-
regulation of occludin and the activation of c-Src
MLE-12 cells were treated with 8% or 20% cyclic
stretching for 0, 1, 2 and 4 h. Occludin levels and total
and phosphorylation of c-Src were detected by western
blotting. Occludin expression was not significantly chan-
ged at 8% cyclic stretching (P > 0.05) (Figure 1). At 20%
cyclic stretching, the expression of occludin was reduced
in a time-dependent manner, reaching a final reduction
of 70% at 4 h (P < 0.05) (Figure 1). After exposure of
MLE-12 cells to 20% cyclic stretching for 0, 1, 2 and 4 h,
c-Src was activated, and the level of total and phosphor-
ylation c-Src increased (P < 0.05) (Figure 2).
The c-Src inhibitor PP2 can rescue the cyclic stretching in-
duced occludin loss
MLE-12 cells were randomly divided into four groups: a
control group; a stretching group, with 20% cyclic
stretching for 4 h; a DMSO group, treated with DMSO
for 30 min before stretching; and a PP2 group, pre-
treated with PP2 for 30 min before stretching. The ex-
pression of occludin and c-Src were analyzed by western
blotting. The expression of occludin and total and phos-
phorylation c-Src in the stretching and DMSO groups
did not significant change (P > 0.05) (Figure 3A,B,C).
DMSO used to dilute PP2 was therefore not related to
the reduction of occludin or the activation of c-Src.
Total and phosphorylated c-Src levels in the PP2 group
were lower than those levels in the stretching group
(P < 0.05) (Figure 3B,C), Occludin levels in the PP2
group were higher than those levels in the stretching
group (P < 0.05) (Figure 3A), indicating that PP2 can re-
verse the expression of occludin.
With immunofluorescence, we observed the same
distribution of occludin in the stretching and DMSO
groups. The distribution of occludin in the stretching
group was more limited under microscope than the con-
trol group. Compared with the stretching group, occlu-
din distribution in the PP2 group showed a broader
scope (Figure 3D).
The relationship between occludin and c-Src was further
confirmed by occludin-siRNA
MLE-12 cells were manipulated at 10 nM, 20 nM and
30 nM concentrations of occludin-siRNA to choose
proper concentration for stretching before being exam-
ined by western blotting (P < 0.05) (Figure 4). c-Src levels
did not show significant differences among MLE-12 cells
treating with different concentrations of occludin-siRNA
(P > 0.05) (Figure 5). Compared with MLE-12 cells
that had been stretched, the level of c-Src in MLE-12
cells pretreating with Occludin-siRNA did not change
(P > 0.05) (Figure 5). Knock down of occludin did not
Figure 1 Time course of cyclic stretch-induced degradation of occludin in MLE-12 cells. MLE-12 epithelial cells were exposed to 8% or 20%
cyclic stretching for 0, 1, 2, and 4 h. Occludin expression was determined by Western blotting. The density of proteins in 0 h was used as a
standard (1 arbitrary unit) to compare relative densities in the other times. **P < 0.05,*P < 0.05, compared with 0 h. Data are representative of 3
independent experiments.
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whether cells were stretched.
In vivo expression of occludin and c-Src, and pulmonary
edema
Mechanical ventilation increased the expression of total
and phosphorylation c-Src and the degradation of occlu-
din in group H (P < 0.05) compared with group C and M
(Figure 6), as seen by western blotting. The expression
of occludin was higher and c-Src level was lower in
group H + P compared with group H (P < 0.05) (Figure 6).
HE staining (Figure 7), lung injury score (Table 1) and
W/D ratio (Table 2) showed that high tidal volume
mechanical ventilation could cause alveolar congestion,
infiltration or aggregation of neutrophils in the airspace
or the vessel wall, and thickening of the alveolar
wall. PP2 could ameliorate the lung injury. These resultsFigure 2 Effect of the expressions of total and phosphorylated c-Src o
20% cyclic stretching for 0, 1, 2, and 4 h. A and B: Representative Western
proteins in 0 h was used as a standard (1 arbitrary unit) to compare relative
Data are representative of 3 independent experiments.suggest that high tidal volume mechanical ventilation
can activate c-Src and decrease occludin levels.
Discussion
The mechanisms of VILI are intricate, and studies have
shown that were related with inflammation and barrier
function [19,20]. Processes of inflammation are well
known, but barrier function mechanisms require further
study. The barrier function comprises tight junctions and
adherens junctions. Adherens junctions consist of integral
membrane proteins: E-cadherin, β-catenin, p120-catenin,
and α-catenin [21]. Tight junctions consist of occludin,
the claudin family of proteins, junctional adhesion mole-
cules, and ZO-1, 2, 3 proteins [22].
Mechanical ventilation could damage alveolar barrier
function by down-regulating occludin, potentially lead-
ing to pulmonary edema [23]. Epithelial and endothelialn 20% cyclic stretching. MLE-12 epithelial cells were exposed to
blotting of total and phosphorylated c-Src expressions, the density of
densities in the other times. *P < 0.05, #P < 0.05, compared with 0 h.
Figure 3 Effect of occludin and c-Src expressions on 20% cyclic stretching with PP2 and DMSO. MLE-12 cells were exposed on 20% cyclic
stretching for 4 h. A, B and C: Representative Western blotting of occludin and total and phosphorylated c-Src expressions and the density of
proteins in non-stretching group was used as a standard to compare relative densities in the other groups. *P > 0.05, compared with the DMSO
group. **P < 0.05, ##P < 0.05, #P < 0.05, compared with the PP2 group. Data are representative of 3 independent experiments. D: At the end of
cyclic stretching, cells were fixed, blocked and then incubated with occludin primary antibody, performed overnight at 4°C. Cy3-Goat Anti-Rabbit
IgG (Red) was used as the secondary antibody. Nuclei were counterstained with DAPI (Blue).
Figure 4 Occluin expression in MLE-12 cells treated by different concentrations of occludin-siRNA. MLE-12 epithelial cell monolayers were
incubated with different concentrations. Representative Western blotting of occludin protein expressions and the density of proteins in occludin-siRNA
0nM group was used as a standard to compare relative densities in the other groups. *P < 0.05, compared with the occludin-siRNA 30 nM group. Data
are representative of 3 independent experiments.
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Figure 5 Effect of c-Src expression with different treatments in MLE-12 cells. MLE-12 cells transfected with occludin-siRNA 30 nM were
exposed to 20% cyclic stretching for 4 h. Representative Western blotting of c-Src expressions and the density of proteins in non-stretching group
was used as a standard (1 arbitrary unit) to compare relative densities in the other groups. *P > 0.05, compared with the non-stretching group.
#P > 0.05, compared with the stretching (4 h) group. Data are representative of 3 independent experiments.
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tion, and the excessive expansion and collapse of cells
could damage the integrity of the alveolar membrane,
which is the most usual cause of VILI [20].
In the current study, we focused on the role epithelial
cells play in barrier function. The current method of
stretching alveolar epithelial cells using a stretch machine toFigure 6 Expression of occludin and total and phosphorylated c-Src i
A: Occludin expression was determined by Western blotting analysis and t
(1 arbitrary unit) to compare relative densities in the other groups. ###P < 0.
#P < 0.05, compared with group H. B and C: Total and phosphorylation c-Sr
density in control group was used as a standard (1 arbitrary unit) to compa
compared with group C. &&P < 0.05, **P < 0.05, compared with group M. &
3 independent experiments.simulate lung expansion and contraction is well-recognized
[24]. Experiments have confirmed that a stretch area
expanded by 8–10% is defined as physiological stretch
stimulation, and a stretch area expanded by more than
20–30% as pathological stretch stimulation. Frequency
and maximum amplitude of stretching has been reported
to change cell permeability and barrier function [25]. Inn group C, group M, group M+ P, group H and group H + P.
he density of Occludin in control group was used as a standard
05, compared with group C. ##P < 0.05, compared with group M.
c expressions were determined by Western blotting analysis and the
re relative densities in the other groups. &&&P < 0.05, ***P < 0.05,
P < 0.05, *P < 0.05, compared with group H. Data are representative of
Figure 7 Histological observation of lung injury in group C, group M, group M + P, group H and group H + P. Lung tissue sections were
stained with hematoxylin-eosin (original magnification, ×200). One representative image for each of the lung microscopic photograph in the
(A) group C, (B) group M, (C) group M + P, (D) group H, (E) group H + P, in three independent experiments is shown.
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cyclic stretching for 4 h on cells. The extension of time
also did not change barrier function.
Consistently, we used in vivo models of VILI to inves-
tigate the relationship between c-Src activation and de-
creases in occludin levels. Lung tissue in groups with
high tidal volume exacerbated pulmonary inflammation
and injury. Pathologic changes were serious: alveolar
structures deformed, the alveolar septum thickened, in-
filtration of inflammatory cells increased, and pulmonary
edema present. The W/D ratio was higher and the expres-
sion of occludin was lower in the VILI models. The c-Src
inhibitor PP2 was able to reverse the damage caused, pos-
sibly by decreasing the expression of occludin.
Occludin was the first identified transmembrane
protein in tight junctions, with a molecular weight of
65 kDa [26]. Recent studies found that occludin plays a
key role in barrier function in tight junctions [26,27].
Phosphorylation and endocytosis of occludin could re-
duce barrier function [28,29]. Cyclic stretching would
cause phosphorylation of occludin by c-Src activation inTable 1 Lung injury scores in all groups in vivo
Group Alveolar congestion Hemorrhage Infiltra
Group C 0 0
Group M 0.33 ± 0.52 0
Group M + P 0.33 ± 0.52 0
Group H 1.67 ± 0.82 0
Group H + P 0.50 ± 0.55 0
Data are presented as mean ± SD. *P < 0.05 versus Group C; #P < 0.05 versus Group
each group) according to the following four items: alveolar congestion, hemorrhage
thickness of the alveolar wall/hyaline membrane formation. Each item was graded a
moderate damage; 3, severe damage; and 4, maximal damage.Caco-2 cells [30]. Occludin plays an important role in
pulmonary epithelial barrier function [31]. Whether
occludin participates in the pulmonary epithelial barrier
dysfunction induced by the mechanical stretch remains
to be determined. Our study showed the same results
in pulmonary epithelial barrier function. The data from
the current study indicates that a high tidal volume
decreases the expression of occludin in vivo, and cyclic
stretching showed the same result in vitro; with the ex-
pression of occludin decreasing gradually.
Activation of c-Src is involved in cell signal transduc-
tion and regulating the expression of cell junction pro-
teins [32]. Tyrosine phosphorylation may promote the
degradation of junctional proteins from their cytoskeletal
anchors [33] and cause endothelial gap formation, result-
ing in an increase in vascular permeability [34]. c-Src in-
hibitors could enhance the adhesion function of cells or
the extracellular matrix and improve the barrier function
of endothelial cells [35]. A previous study showed that
increased vascular permeability in mouse lungs venti-
lated at high airway pressures could be blocked by c-Srction of neutrophils Alveolar wall thickness Total score
0 0 0
0.67 ± 0.52 0.5 ± 0.55 1.33 ± 1.51
0.33 ± 0.52 0.33 ± 0.52 1.00 ± 1.26
1.33 ± 0.52 1.5 ± 0.55 4.50 ± 0.84*&
0.50 ± 0.55 0.67 ± 0.82 1.67 ± 1.21#
H; &P < 0.05 versus Group M. Lung injury was scored in each sample (n = 6 for
, infiltration or aggregation of neutrophils in airspace or the vessel wall, and
ccording to a 5-point scale: 0, minimal (little) damage; 1, mild damage; 2,
Table 2 Ratio of wet/dry weight in lung
Groups Ratio of wet/dry
Group C 4.12 ± 0.13
Group M 4.65 ± 0.07
Group M + P 4.34 ± 0.04
Group H 5.43 ± 0.14*,&
Group H + P 4.64 ± 0.10#
Data are presented as mean ± SD. *P < 0.05 versus Group C; #P < 0.05 versus
Group H; &P < 0.05 versus Group M. Data are representative of 6
independent experiments.
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lic stretching, which increases p120-catenin expression,
enhances barrier function and reduces intercellular per-
meability [10]. The effects of c-Src inhibitors on occlu-
din in tight junctions require further study.
The current in vivo and in vitro studies revealed that
both high tidal volume mechanical ventilation and cyclic
stretching resulted in the same phenomenon: they could
activate the phosphorylation of c-Src and increase the deg-
radation of occludin, and the c-Src inhibitor PP2 could re-
verse these processes. Immunofluorescence examination
showed that the inhibitor improved the distribution of
occludin with cyclic stretching; and from HE staining,
lung injury score and W/D ratio in rats, it was observed
that c-Src inhibitor could ameliorate pulmonary edema
and alleviate alveolar hemorrhage, inflammatory cell infil-
tration and destroyed pulmonary architecture.
Recent studies have reported that occludin and c-Src
are involved in VILI [16,37]. Our findings from the
current study are consistent with these reports. The ef-
fects occludin and c-Src played in VILI, and whether
occludin and c-Src are concomitant phenomenon or
have a causal relationship remain to be explored. In this
study, western blotting showed that high volume mech-
anical ventilation activated the phosphorylation c-Src
and decreased occludin level, PP2 could decrease the
degradation of occludin in vitro and in vivo. And in vitro
MLE-12 cells treated with occludin-siRNA did not result
in a change of c-Src with cyclic stretching. That is to
say, decreased occludin expression did not affect c-Src
activation. There does, however, appear to be a causal
relationship by cyclic stretching activating c-Src, which
in turn decreases the expression of occluding, but not a
concomitant phenomenon or occludin decreased af-
fected the activation of phosphorylated c-Src.
Conclusions
The results from this study show that VILI down-regulates
the expression of the tight junction protein occludin and
weakens the epithelial barrier. VILI can activate c-Src and
induce a decrease in occludin expression. c-Src inhibitor
was able to alleviate the degradation of occludin, strengthen
tight junctions and reduce pulmonary edema in VILI. Ourresults suggest that c-Src may be an important kinase in
VILI. Inhibition of c-Src activation may be a novel and ef-
fective target for the prevention and treatment of VILI.
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